{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-032025","form_type":"8-K","ticker":"NUS","cik":"0001021561","company_name":"NU SKIN ENTERPRISES, INC.","filed_at":"2026-08-10T20:15:38+00:00","discovered_at":"2026-08-10T20:17:06.323655+00:00","generated_at":"2026-08-10T20:17:37.300722+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Nu Skin Q2 revenue down 17% to $320M; GAAP EPS -$5.14, adjusted $0.20","bullets":["Revenue $320.1M, down 17.1% YoY; FX impact -$4.0M.","GAAP EPS $(5.14) incl. impairment/tax charges; adjusted EPS $0.20 vs $0.43 prior.","Customers 660,037 (-14%), paid affiliates 120,291 (-8%), sales leaders 26,998 (-9%).","Q3 guide: revenue $310-340M, adjusted EPS $0.10-$0.20; FY26 revenue $1.28-1.35B, adjusted EPS $0.70-$0.90.","Dividend payments $2.9M; stock repurchases $0; $137.3M authorization remaining."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-032025","json":"https://secwatch.observer/filing/0001140361-26-032025.json","markdown":"https://secwatch.observer/filing/0001140361-26-032025.md","text":"https://secwatch.observer/filing/0001140361-26-032025.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1021561/000114036126032025/0001140361-26-032025-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1021561/000114036126032025/ef20079831_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-10T20:17:37.300722+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}